New obesity drug retatrutide shows major weight loss in trial

Summarised from 2 outlets · Updated 30 Sept, 02:55 · Archive

Retatrutide, a new weight-loss drug mimicking three gut hormones, helped people lose up to 25 per cent of body weight.

Retatrutide, which targets three key gut hormones—GLP-1, GIP and glucagon—produced significant weight loss in the largest study of its kind, with people losing up to a quarter of their body weight. The drug also improved blood sugar levels and reduced inflammation, though it is not yet approved by any regulatory agency.

How it is being reported

• Most powerful obesity drug yet: People lost up to 25% of weight in trialArs Technica · 29 Sept, 23:30
• ‘Godzilla’ of weight-loss drugs could provide other important health benefitsThe Guardian · 29 Sept, 23:01

In this story: Retatrutide · Wegovy · Mounjaro

This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem